Melperon
(Preusmjereno sa stranice DKMFBWQBDIGMHM-UHFFFAOYSA-N)
Melperon (Buronil, Burnil, Eunerpan) je atipični antipsihotik iz butirofenonske hemijske klase.
(IUPAC) ime | |||
---|---|---|---|
1-(4-fluorofenil)-4-(4-metil-1-piperidil)butan-1-on | |||
Klinički podaci | |||
AHFS/Drugs.com | Internacionalno ime leka | ||
Identifikatori | |||
CAS broj | 3575-80-2 | ||
ATC kod | N05AD03 | ||
PubChem[1][2] | 15387 | ||
ChemSpider[3] | 14646 | ||
UNII | J8WA3K39B7 | ||
KEGG[4] | D07309 | ||
Hemijski podaci | |||
Formula | C16H22FNO | ||
Mol. masa | 263,35 g/mol | ||
SMILES | eMolekuli & PubHem | ||
| |||
Farmakokinetički podaci | |||
Metabolizam | Hepatički (inhibira CYP2D6[5]) | ||
Poluvreme eliminacije | 3–4 časa (oralno) 6 časova (intramuskularno) | ||
Farmakoinformacioni podaci | |||
Trudnoća | ? | ||
Pravni status | |||
Način primene | Oralno, intramuskularna injekcija |
Reference uredi
- ↑ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519.
- ↑ Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.
- ↑ Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846.
- ↑ Joanne Wixon, Douglas Kell (2000). „Website Review: The Kyoto Encyclopedia of Genes and Genomes — KEGG”. Yeast 17 (1): 48–55. DOI:10.1002/(SICI)1097-0061(200004)17:1<48::AID-YEA2>3.0.CO;2-H.
- ↑ Grözinger M, Dragicevic A, Hiemke C, Shams M, Müller MJ, Härtter S (2003). „Melperone is an inhibitor of the CYP2D6 catalyzed O-demethylation of venlafaxine”. Pharmacopsychiatry 36 (1): 3–6. DOI:10.1055/s-2003-38084. PMID 12649767.
Spoljašnje veze uredi
- Melperon
- Clinical Trials NCT00125138